SCHEMBL1763199

SCHEMBL1763199

c1ccc2c([C@@H]3CC[C@@H](c4cccc5ccccc45)N3)cccc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.50
MTNR1A P48039 2/20 0.46
IDO1 P14902 1/20 0.46
SLC6A4 P31645 6/20 0.44
SLC6A2 P23975 3/20 0.44
SLC6A3 Q01959 3/20 0.44
DRD2 P14416 1/20 0.42
EGFR P00533 1/20 0.41
ERBB2 P04626 1/20 0.41
MTNR1B P49286 1/20 0.39
MAPK1 P28482 2/20 0.39
FAAH O00519 1/20 0.39
NPC1 O15118 1/20 0.39
PLA2G6 O60733 1/20 0.39
GMNN O75496 1/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
MTOR P42345 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1763476 1.00 KDM1A (0.50) KDM1AMTNR1AIDO1SLC6A4SLC6A2
SCHEMBL28508192 0.87 KDM1A (0.43) KDM1AMTNR1AIDO1SLC6A4SLC6A2
SCHEMBL31369542 0.82 CYP2C9 (0.45) KDM1AMTNR1AIDO1MTNR1BPLA2G6
SCHEMBL13811323 0.81 KDM1A (0.52) KDM1AMTNR1AIDO1SLC6A4SLC6A2
SCHEMBL2724251 0.79 GRIN2D (0.48) SLC6A3
SCHEMBL5095438 0.79 GRIN2D (0.48) SLC6A3
SCHEMBL29468003 0.79 GRIN2D (0.48) SLC6A3
SCHEMBL10800761 0.79 MTNR1A (0.50) KDM1AMTNR1AIDO1SLC6A4SLC6A2
SCHEMBL7705258 0.77 KDM1A (0.44) KDM1AMTNR1AIDO1SLC6A4SLC6A2
SCHEMBL4149119 0.77 SCN9A (0.46) KDM1AMTNR1AIDO1SLC6A4SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8759541-B2 Chiral acyclic diaminocarbene ligands, precursors therefore and their use in organic synthesis reactions THADANI AVINASH N (CA) 2014-06-24 US disclosed
US-20110118475-A1 CHIRAL ACYCLIC DIAMINOCARBENE LIGANDS, PRECURSORS THEREFORE AND THEIR USE IN ORGANIC SYNTHESIS REACTIONS THADANI AVINASH N 2011-05-19 US disclosed
WO-2010003226-A1 CHIRAL ACYCLIC DIAMINOCARBENE LIGANDS, PRECURSORS THEREFORE AND THEIR USE IN ORGANIC SYNTHESIS REACTIONS THADANI AVINASH N (CA) 2010-01-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118475-A1 CHIRAL ACYCLIC DIAMINOCARBENE LIGANDS, PRECURSORS THEREFORE AND THEIR USE IN ORGANIC SYNTHESIS REACTIONS AOC1, ODC1, AMD1 KDM1A 3656/4885MTNR1A 2992/4885IDO1 1747/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.